Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.82 |
| ▸ | TSHR | P16473 | 1/20 | 0.82 |
| ▸ | PLA2G4B | P0C869 | 8/20 | 0.80 |
| ▸ | RARB | P10826 | 4/20 | 0.76 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.72 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.59 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.59 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9649608 | 1.00 | TP53 (0.82) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL5692920 | 1.00 | TP53 (0.82) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL14984230 | 1.00 | TP53 (0.82) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL9649614 | 1.00 | TP53 (0.82) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| Hydrochloric Acid SCHEMBL7991872 | 0.94 | TP53 (0.71) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL1322922 | 0.91 | TP53 (1.00) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL1469965 | 0.91 | TP53 (1.00) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL371494 | 0.91 | TP53 (1.00) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL3625733 | 0.91 | TP53 (1.00) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL10777726 | 0.91 | TP53 (1.00) | TP53TSHRPLA2G4BRARBPLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8481129-B2 | Liquid crystal compounds, and liquid crystal displays and photochromic materials comprising the liquid crystal compounds | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-07-09 | — | — | US | disclosed |
| US-20130135574-A1 | LIQUID CRYSTAL COMPOUNDS, AND LIQUID CRYSTAL DISPLAYS AND PHOTOCHROMIC MATERIALS COMPRISING THE LIQUID CRYSTAL COMPOUNDS | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130135574-A1 | LIQUID CRYSTAL COMPOUNDS, AND LIQUID CRYSTAL DISPLAYS AND PHOTOCHROMIC MATERIALS COMPRISING THE LIQUID CRYSTAL COMPOUNDS | H1-0, H1-10, FOXK1 | TP53 674/4885TSHR 3460/4885PLA2G4B 3972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.